Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Non-malignant Disease
What is the role of RT in neurosarcoidosis that is refractory to a variety of medical therapies?
What dose/fractionation should be used?
Would you consider giving memantine in these situations?
Related Questions
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
For those treating osteoarthritis with LDRT, is there any concern of adverse effects or decreased efficacy in patients with osteoporosis?
What radiation dose and margins would you recommend for treatment of a progressive cerebellar glioma with BCOR/BCOR1 fusion after initial subtotal resection with residual disease adjacent to the posterior brainstem.
Do you still recommend protons for grade 2 and grade 3 glioma, following the Soprano study results showing a survival detriment?
Are you offering Lutathera for multiple recurrent meningiomas?
What fractionation would you use for a young patient with a schwannoma that has regrown within 2 years of resection?
Do you offer low-dose radiation therapy for osteoarthritis of the spine?
Do you utilize tumor treating fields in patients with anaplastic pleomorphic xanthoastrocytoma (PXA) III?
What is the role of radiation in intra labyrinthine (cochlear) schwannoma?
What would be your radiotherapy plan for a patient with recurrent GBM (WHO grade 4, IDH wild-type) s/p 2 prior resections with no prior radiation?